| 1. | mikecontreras2017 | |
| 2. | kinderreadypuent | |
| 3. | russawye9 | |
| 4. | kevinkev78 | |
| 5. | xenstuff |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | kevinkev78 03/01/2018 argenx reports fourth quarter business update and full year 2017 financial results |
| 2. | xenstuff 01/29/2018 already close to the target |
| 3. | toddy709086 04/24/2018 argenx to present complete data from the Phase 2 proof-of-concept trial of efgartigimod (ARGX-113) in generalized myasthenia gravis at American Academy of Neurology (AAN) Annual Meeting |
| 4. | kevinkev78 01/29/2018 HEY WoW! Loving the chart |
| 5. | mikecontreras2017 04/10/2018 SunTrust Robinson Humphrey initiates as a buy, $125PT |
| 6. | xenstuff 03/22/2018 Announces the addition of a new pipeline candidate, ARGX-117, targeting the complement cascade with therapeu… |
| 7. | kinderreadypuent 01/29/2018 JMP Securities raises price target to $87 from $74 |
| 8. | kevinkev78 06/20/2018 argenx reports interim data from first cohort of Phase 2 proof-of-concept clinical trial of efgartigimod for the treatment of pemphigus vulgaris |
| 9. | xenstuff 04/12/2018 argenx to receive third preclinical milestone payment from collaboration with LEO Pharma - Milestone associated with CTA approval for ARGX-112 |
| 10. | mikecontreras2017 01/29/2018 {Image} |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
argenx SE
- ARGX
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.